Randomized, Open Label, Stratified Phase 2 Trial of Gemcitabine, Carboplatin, and Cetuximab With Vs. Without IMC-A12 in Chemotherapy-Naive Patients With Advanced/Metastatic Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Carboplatin; Cetuximab; Cisplatin; Cixutumumab; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 13 Jun 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.